Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jul 01, 2006 (Vol. 26, No. 13)

Hypertension Online

URL:www.hypertensionline.org
  • Focused educational content
  • Not very broad
Self-described as "a cutting-edge educational resource for reliable information and tools relevant to the field of hypertension," Hypertension Online is an interesting disappointment. It is interesting in that it provides useful resources to visitors, including downloadable slide libraries and animations aimed at physicians and researchers to use for education. Also, the site’s ’Late-Breaking Trials’ information is, as its name suggests, current and relevant for this important area. Where Hypertension Online is disappointing, though, is in broad educational content, organization, and breadth of coverage. While it is not unreasonable for a site to define a narrow focus, this one’s name suggests it is more wide ranging than it really is.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »